Literature DB >> 27418867

In Vitro Antifungal Activities against Moulds Isolated from Dermatological Specimens.

Tzar Mohd Nizam1, Rabiatul Adawiyah Ag Binting2, Shafika Mohd Saari2, Thivyananthini Vijaya Kumar2, Marianayati Muhammad1, Hartini Satim1, Hamidah Yusoff1, Jacinta Santhanam2.   

Abstract

BACKGROUND: This study aimed to determine the minimum inhibitory concentrations (MICs) of various antifungal agents against moulds isolated from dermatological specimens.
METHODS: We identified 29 moulds from dermatological specimens between October 2012 and March 2013 by conventional methods. We performed antifungal susceptibility testing on six antifungal agents, amphotericin B, clotrimazole, itraconazole, ketoconazole, miconazole and terbinafine, according to the Clinical and Laboratory Standards Institute guidelines contained in the M38-A2 document.
RESULTS: Most antifungal agents were active against the dermatophytes, except for terbinafine against Trichophyton rubrum (geometric mean MIC, MICGM 3.17 μg/mL). The dematiaceous moulds were relatively susceptible to amphotericin B and azoles (MICGM 0.17-0.34 μg/mL), but not to terbinafine (MICGM 3.62 μg/mL). Septate hyaline moulds showed variable results between the relatively more susceptible Aspergillus spp. (MICGM 0.25-4 μg/mL) and the more resistant Fusarium spp. (MICGM 5.66-32 μg/mL). The zygomycetes were susceptible to amphotericin B (MICGM 0.5 μg/mL) and clotrimazole (MICGM 0.08 μg/mL), but not to other azoles (MICGM 2.52-4 μg/mL).
CONCLUSION: Amphotericin B and clotrimazole were the most effective antifungal agents against all moulds excepting Fusarium spp., while terbinafine was useful against dermatophytes (except T. rubrum) and Aspergillus spp. However, a larger study is required to draw more solid conclusions.

Entities:  

Keywords:  amphotericin B; antifungal; azoles; dermatology; mold; terbinafine

Year:  2016        PMID: 27418867      PMCID: PMC4934716     

Source DB:  PubMed          Journal:  Malays J Med Sci        ISSN: 1394-195X


  20 in total

1.  Antifungal susceptibility and phylogeny of opportunistic members of the order mucorales.

Authors:  Roxana G Vitale; G Sybren de Hoog; Patrick Schwarz; Eric Dannaoui; Shuwen Deng; Marie Machouart; Kerstin Voigt; Wendy W J van de Sande; Somayeh Dolatabadi; Jacques F Meis; Grit Walther
Journal:  J Clin Microbiol       Date:  2011-11-09       Impact factor: 5.948

2.  Itraconazole therapy is effective for pedal onychomycosis caused by some nondermatophyte molds and in mixed infection with dermatophytes and molds: a multicenter study with 36 patients.

Authors:  P R De Doncker; R K Scher; R L Baran; J Decroix; H J Degreef; D I Roseeuw; V Havu; T Rosen; A K Gupta; G E Piérard
Journal:  J Am Acad Dermatol       Date:  1997-02       Impact factor: 11.527

3.  In vitro evaluation of the type of interaction obtained by the combination of terbinafine and itraconazole, voriconazole, or amphotericin B against dematiaceous molds.

Authors:  Fernanda Simas Corrêa Biancalana; Luzia Lyra; Angélica Zaninelli Schreiber
Journal:  Antimicrob Agents Chemother       Date:  2011-06-20       Impact factor: 5.191

Review 4.  Combination antifungal therapy for disseminated fusariosis in immunocompromised patients : a case report and literature review.

Authors:  Jyh-You Liu; Wei-Ting Chen; Bor-Sheng Ko; Ming Yao; Po-Ren Hsueh; Cheng-Hsiang Hsiao; Yu-Min Kuo; Yee-Chun Chen
Journal:  Med Mycol       Date:  2011-03-30       Impact factor: 4.076

5.  Itraconazole in the treatment of tinea capitis.

Authors:  R Legendre; J Esola-Macre
Journal:  J Am Acad Dermatol       Date:  1990-09       Impact factor: 11.527

6.  Successful salvage treatment of disseminated cutaneous fusariosis with liposomal amphotericin B and terbinafine after allogeneic stem cell transplantation.

Authors:  S Neuburger; G Massenkeil; M Seibold; C Lutz; I Tamm; P le Coutre; B Graf; B Doerken; R Arnold
Journal:  Transpl Infect Dis       Date:  2008-01-14       Impact factor: 2.228

7.  In vitro activities of antifungal drugs against dermatophytes isolated in Tokat, Turkey.

Authors:  Gülgün Yenişehirli; Ebru Tunçoğlu; Aydan Yenişehirli; Yunus Bulut
Journal:  Int J Dermatol       Date:  2013-10-18       Impact factor: 2.736

8.  Antifungal susceptibility profile of clinical Fusarium spp. isolates identified by molecular methods.

Authors:  Ana Alastruey-Izquierdo; Manuel Cuenca-Estrella; Araceli Monzón; Emilia Mellado; Juan Luís Rodríguez-Tudela
Journal:  J Antimicrob Chemother       Date:  2008-02-08       Impact factor: 5.790

9.  Subcutaneous zygomycosis of the cervicotemporal region: Due to Basidiobolus ranaram.

Authors:  Roshan Kumar Verma; M R Shivaprakash; Amit Shanker; Naresh K Panda
Journal:  Med Mycol Case Rep       Date:  2012-08-04

10.  Microscopic evaluation, molecular identification, antifungal susceptibility, and clinical outcomes in fusarium, Aspergillus and, dematiaceous keratitis.

Authors:  Devarshi U Gajjar; Anuradha K Pal; Bharat K Ghodadra; Abhay R Vasavada
Journal:  Biomed Res Int       Date:  2013-10-24       Impact factor: 3.411

View more
  2 in total

1.  Molecular Epidemiology and Antifungal Susceptibility of Trichophyton Isolates in Greece: Emergence of Terbinafine-Resistant Trichophytonmentagrophytes Type VIII Locally and Globally.

Authors:  Maria Siopi; Ioanna Efstathiou; Konstantinos Theodoropoulos; Spyros Pournaras; Joseph Meletiadis
Journal:  J Fungi (Basel)       Date:  2021-05-27

2.  A 23 bp cyp51A Promoter Deletion Associated With Voriconazole Resistance in Clinical and Environmental Isolates of Neocosmospora keratoplastica.

Authors:  Jasper Elvin James; Erwin Lamping; Jacinta Santhanam; Trudy Jane Milne; Mohd Fuat Abd Razak; Latiffah Zakaria; Richard David Cannon
Journal:  Front Microbiol       Date:  2020-03-31       Impact factor: 5.640

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.